OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company’s first AI agent that can act autonomously on the web. But OpenAI is not Altman ...

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

ForbesMusk Bashes Trump’s New Stargate AI Initiative With OpenAI And Oracle As ‘Fake’—Here’s WhyBy Derek Saul ForbesOpenAI’s Sam Altman Says He ‘Changed His Perspective’ On Trump ...

Elon Musk, the CEO of Tesla and SpaceX, is in a heated dispute with OpenAI CEO Sam Altman over the Stargate AI infrastructure project backed by President Donald Trump, which promises up to $500 ...